Invention Grant
- Patent Title: Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
-
Application No.: US14053544Application Date: 2013-10-14
-
Publication No.: US09029404B2Publication Date: 2015-05-12
- Inventor: George A. Doherty , Steven W. Elmore , Laura A. Hexamer , Robert A. Mantei , Andrew J. Souers , Gerard M. Sullivan , Zhi-Fu Tao , Gary T. Wang , Le Wang , Xilu Wang , Todd M. Hansen
- Applicant: AbbVie Inc.
- Applicant Address: US IL North Chicago
- Assignee: AbbVie Inc.
- Current Assignee: AbbVie Inc.
- Current Assignee Address: US IL North Chicago
- Agency: Jones Day
- Main IPC: A61K31/404
- IPC: A61K31/404 ; A61K31/416 ; C07D403/14 ; C07D413/14 ; C07D213/76 ; C07D209/08 ; C07D211/58 ; C07D213/74 ; C07D213/84 ; C07D231/56 ; C07D235/06 ; C07D277/24 ; C07D295/30 ; C07D309/04 ; C07D401/14 ; C07D405/12 ; C07D405/14 ; C07D413/12 ; C07D417/12 ; C07D471/04 ; A61K31/495 ; A61K31/496 ; A61K31/5377 ; A61K45/06 ; C07D211/06 ; C07D295/14 ; C07D309/32 ; C07D403/12
Abstract:
Disclosed are compounds which inhibit the activity of anti-apoptotic Bcl-2 proteins, compositions containing the compounds and methods of treating diseases during which is expressed anti-apoptotic Bcl-2 protein.
Public/Granted literature
- US20140088106A1 APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE AND AUTOIMMUNE DISEASES Public/Granted day:2014-03-27
Information query
IPC分类:
